Xcout Intel
IDL Diagnostics
IDL Diagnostics (formerly AroCell) develops and provides medical diagnostic products focusing on oncology and bacteriology. The company offers specialized tests and assays, such as tumor markers and rapid diagnostic solutions, to healthcare providers and researchers.
Subscribe to see IDL Diagnostics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
IDL Diagnostics at a glance
IDL Diagnostics is a health care company headquartered in Sweden. Xcout tracks 5 named people at IDL Diagnostics, including Gustav Sten (CEO).
IDL Diagnostics leadership
- Gustav StenCEO
- Max PihlqvistChairman
- Clas RunnbergBoard member
- Eva NordströmBoard member
- Per-Anders AbrahamssonBoard member
IDL Diagnostics competitors
A few of IDL Diagnostics's closest competitors — see the full list of competitors and alternatives →
EarlyDiagnostics, also known as EarlyDx, is a clinical-stage precision diagnostics company that develops non-invasive liquid biopsy technologies and genomics platforms for early cancer detection.
2cureX develops products for individualized therapy selection in oncology, utilizing 3D cell culture technologies to create patient-derived tumor models for drug sensitivity testing. Its IndiTreat technology enables healthcare professionals to evaluate drug responses using 3D microtumors, helping doctors select optimal cancer treatments for individual patients.
Proteomedix is a Swiss diagnostics company and spin-out of ETH Zurich dedicated to developing innovative diagnostic solutions, such as prostate cancer tests.
AOA Dx Inc. is a US-based diagnostics biotechnology company with offices in Boston, New York, and London, focusing on the early detection of ovarian cancer.
Celsee Diagnostics is a company operating in the rare disease diagnostics and liquid biopsy market. Based in Maryland, the company is involved in developing and assessing advanced healthcare technologies for cancer and genomic detection.
BioVendor Group is an international group of biotechnology companies headquartered in Brno, Czech Republic, specializing in immunodiagnostics and molecular diagnostics. The group partners with healthcare-focused investment firms to deliver comprehensive laboratory medicine solutions globally.
Get IDL Diagnostics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on IDL Diagnostics in Xcout Intel
- 5 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access